In what it describes as a “substantial boost” for the UK’s vaccine manufacturing capacity, the government has announced an additional £100m (US$130m) in funding for a state-of-the-art production cente
Rising evidence that interferons could be used as potential treatments for COVID-19 led last month to Canada-based BetterLife Pharma Inc. acquiring Altum Pharmaceuticals Inc. , giving it ownership
IN VITRO DIAGNOSTICS Alliances Dentamed Ltd. Diamedica Ltd. SIRAM Ltd. Vigilant Biosciences Inc. Vigilant Biosciences Inc. signed three new multi-year distribution agreements for marketing of its